- Home
- SSSS vs PROF Comparison
SSSS vs PROF Comparison
Compare SSSS & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSSS
- PROF
- Stock Information
- Founded
- SSSS 2010
- PROF N/A
- Country
- SSSS United States
- PROF Canada
- Employees
- SSSS N/A
- PROF N/A
- Industry
- SSSS Finance: Consumer Services
- PROF Medical/Dental Instruments
- Sector
- SSSS Finance
- PROF Health Care
- Exchange
- SSSS Nasdaq
- PROF Nasdaq
- Market Cap
- SSSS 138.2M
- PROF 149.7M
- IPO Year
- SSSS N/A
- PROF N/A
- Fundamental
- Price
- SSSS $8.73
- PROF $4.74
- Analyst Decision
- SSSS Strong Buy
- PROF Strong Buy
- Analyst Count
- SSSS 4
- PROF 1
- Target Price
- SSSS $9.50
- PROF $11.00
- AVG Volume (30 Days)
- SSSS 255.3K
- PROF 157.4K
- Earning Date
- SSSS 08-06-2025
- PROF 08-14-2025
- Dividend Yield
- SSSS 11.44%
- PROF N/A
- EPS Growth
- SSSS N/A
- PROF N/A
- EPS
- SSSS 2.22
- PROF N/A
- Revenue
- SSSS $2,784,381.00
- PROF $11,840,000.00
- Revenue This Year
- SSSS $6.95
- PROF $63.99
- Revenue Next Year
- SSSS N/A
- PROF $117.19
- P/E Ratio
- SSSS $3.94
- PROF N/A
- Revenue Growth
- SSSS N/A
- PROF 59.81
- 52 Week Low
- SSSS $3.75
- PROF $3.90
- 52 Week High
- SSSS $9.12
- PROF $9.71
- Technical
- Relative Strength Index (RSI)
- SSSS 57.61
- PROF 39.03
- Support Level
- SSSS $8.28
- PROF $4.31
- Resistance Level
- SSSS $8.55
- PROF $5.96
- Average True Range (ATR)
- SSSS 0.27
- PROF 0.36
- MACD
- SSSS 0.00
- PROF -0.08
- Stochastic Oscillator
- SSSS 78.48
- PROF 28.65
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.